Shortcomings in the clinical evaluation of new drugs: acute myeloid leukemia as paradigm

Drugs introduced over the past 25 years have benefitted many patients with acute myeloid leukemia (AML) and provided cure for some. Still, AML remains difficult to treat, and most patients will eventually die from their disease. Therefore, novel drugs and drug combinations are under intense investig...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Walter, Roland B., Appelbaum, Frederick R., Tallman, Martin S., Weiss, Noel S., Larson, Richard A., Estey, Elihu H.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2010
Assuntos:
Perspectives
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2953881/
https://ncbi.nlm.nih.gov/pubmed/20538802
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2010-05-285387
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados